Literature DB >> 8939888

Structure and expression of the ATFa gene.

J Goetz1, B Chatton, M G Mattei, C Kedinger.   

Abstract

The human ATFa proteins belong to the ATF/CREB family of transcription factors. We have previously shown that they mediate the transcriptional activation by the largest E1a protein and can heterodimerize with members of the Jun/Fos family. ATFa proteins have also been found tightly associated with JNK2, a stress-activated kinase. We now report on the structure of the ATFa gene, which mapped to chromosome 12 (band 12q13). Sequence analysis revealed that ATFa isoforms are generated by alternative splice donor site usage. A minimal promoter region of approximately 200 base pairs was identified that retained nearly full transcriptional activity. Binding sites for potential transcription factors were delineated within a GC-rich segment by DNase I footprinting. Expression studies revealed that ATFa accumulates in the nuclei of transfected cells, and the nuclear localization signal was defined next to the leucine zipper domain. As revealed by hybridization with mouse ATFa sequences, low levels of ATFa mRNAs were ubiquitously distributed in fetal or adult mice, with enhanced expression in particular tissues, like squamous epithelia and specific brain cell layers. The possible significance of coexpression of ATFa, ATF-2, and Jun at similar sites in the brain is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939888     DOI: 10.1074/jbc.271.47.29589

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  ATF7 is stabilized during mitosis in a CDK1-dependent manner and contributes to cyclin D1 expression.

Authors:  Etienne Schaeffer; Marc Vigneron; Annie-Paule Sibler; Mustapha Oulad-Abdelghani; Bruno Chatton; Mariel Donzeau
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  The product of the adenovirus intermediate gene IX is a transcriptional activator.

Authors:  P Lutz; M Rosa-Calatrava; C Kedinger
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Social isolation stress induces ATF-7 phosphorylation and impairs silencing of the 5-HT 5B receptor gene.

Authors:  Toshio Maekawa; Seungjoon Kim; Daisuke Nakai; Chieko Makino; Tsuyoshi Takagi; Hiroo Ogura; Kazuyuki Yamada; Bruno Chatton; Shunsuke Ishii
Journal:  EMBO J       Date:  2009-11-05       Impact factor: 11.598

4.  The 2 micrometer plasmid stability system: analyses of the interactions among plasmid- and host-encoded components.

Authors:  S Velmurugan; Y T Ahn; X M Yang; X L Wu; M Jayaram
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

Review 5.  Inheritance and memory of stress-induced epigenome change: roles played by the ATF-2 family of transcription factors.

Authors:  Ki-Hyeon Seong; Toshio Maekawa; Shunsuke Ishii
Journal:  Genes Cells       Date:  2012-03-01       Impact factor: 1.891

6.  A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.

Authors:  Jessica Diring; Barbara Camuzeaux; Mariel Donzeau; Marc Vigneron; Manuel Rosa-Calatrava; Claude Kedinger; Bruno Chatton
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

7.  Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity.

Authors:  Pierre-Jacques Hamard; Michaël Boyer-Guittaut; Barbara Camuzeaux; Denis Dujardin; Charlotte Hauss; Thomas Oelgeschläger; Marc Vigneron; Claude Kedinger; Bruno Chatton
Journal:  Nucleic Acids Res       Date:  2007-01-30       Impact factor: 16.971

8.  Cdk1-mediated phosphorylation of human ATF7 at Thr-51 and Thr-53 promotes cell-cycle progression into M phase.

Authors:  Hitomi Hasegawa; Kenichi Ishibashi; Shoichi Kubota; Chihiro Yamaguchi; Ryuzaburo Yuki; Haruna Nakajo; Richard Eckner; Noritaka Yamaguchi; Kazunari K Yokoyama; Naoto Yamaguchi
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

Review 9.  The regulatory role of activating transcription factor 2 in inflammation.

Authors:  Tao Yu; Yong Jun Li; Ai Hong Bian; Hui Bin Zuo; Ti Wen Zhu; Sheng Xiang Ji; Fanming Kong; De Qing Yin; Chuan Bao Wang; Zi Fu Wang; Hong Qun Wang; Yanyan Yang; Byong Chul Yoo; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2014-06-23       Impact factor: 4.711

10.  Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells.

Authors:  Lifang Luo; Lijing Cai; Laibang Luo; Zhimou Tang; Xiaohui Meng
Journal:  Mol Med Rep       Date:  2018-04-23       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.